BioMarin Pharmaceutical Inc. (NASDAQ: BMRN): BMO Capital Markets upgraded the stock to Outperform from Market Perform. Its $102 target price is lower than the consensus target of $119.22. Wednesday’s close was at $87.27.
Coherent Corp. (NYSE: COHR): As Barclays upgraded the stock to Equal Weight from Underweight, its $29 target price jumped to $45. The consensus target is $46.60. The stock closed on Wednesday at $50.61.
Coinbase Global Inc. (NASDAQ: COIN): Piper Sandler downgraded the shares to Neutral from Overweight and trimmed its $65 price target to $60. Shares have traded as high as $116.30 in the past year but closed on Wednesday at $78.35.
Conagra Brands Inc. (NYSE: CAG): The Jefferies downgrade was from Buy to Hold with a $38 target price. The consensus is $41.64, and the stock closed on Wednesday at $33.67.
Coty Inc. (NYSE: COTY): BofA Securities reiterated a Buy rating. Its $14 target price compares with the consensus target of $13.39 and Wednesday’s $12.52 closing share price.
GlobalFoundries Inc. (NASDAQ: GFS): Its Bear of the Day stock is struggling to draw new business in the AI-chip war, says Zacks. Shares have traded as high as $72.50 in the past year but closed most recently at $63.35.
Hertz Global Holdings Inc. (NYSE: HTZ): Jefferies initiated coverage with a Buy rating and a target price of $24. The consensus target is $25. The shares closed on Wednesday at $18.76.
Motorola Solutions Inc. (NYSE: MSI): J.P. Morgan resumed coverage with an Overweight rating and a $329 target price. The consensus target is $304.90. The shares ended Wednesday trading at $292.74.
Netflix Inc. (NASDAQ: NFLX): Goldman Sachs upgraded the shares to Neutral from Sell. The analyst also boosted its $230 target price to $400, above the consensus target of $395.37. Wednesday’s close was at $445.90.
Noble Corp. PLC (NYSE: NE): Citigroup started coverage with a Buy rating and a $64 target price. The consensus target is $55.38. The stock closed on Wednesday at $43.46, up almost 3% for the day on the initiation.
Nucor Corp. (NYSE: NUE): Exane BNP Paribas upgraded the stock to Outperform from Neutral. Its $191 target price is well above the consensus target of $150.08. Wednesday’s $160.45 close was down over 3% on the day.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
